Publication on NanoMosaic Technology in the, "British Journal of Anaesthesia"

BOSTON, Sept. 20, 2022 /PRNewswire/ -- With NanoMosaic's nanoneedle technology, researchers from Massachusetts General Hospital and Harvard Medical School detected Tau and phosphor-Tau proteins in serum samples from patients under major cardiac surgery with cardiopulmonary bypass. Elevation of Tau and phosphor-Tau proteins were observed before and after the surgery, and Tau protein is identified as a potential serum biomarker of delirium after cardiac surgery. The study has been published in the British Journal of Anaesthesia.